Thrombocytosis and Megakaryocytic Proliferation Are the Early Presentations in Patients With Jak2-Positive Myeloproliferative Neoplasm at age 50 or Younger With Clinical Follow-up and Cytogenetic Correlation | American Journal of Clinical Pathology | DeepDyve